Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Reduced-Intensity Versus Myeloablative Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials & Cohort Studies

Arshia Akbar, MDMBBS, Zunairah Shah, MBBS, Muhammad Ali Aziz, MD, Muhammad Yasir Anwar, Saman Bahram, Waqas Khan, Zahoor Ahmed, MD, Qasim Khurshid, MD, Abdul Jabbar Dar, MD, Anum Javaid, MD, Neelam Asghar, Harsh Patel, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-138771

Published: 2020

Journal Articles

MEK Inhibition with Trametinib in Patients with Non-Langerhans Cell Histiocytosis

Filip Janku, MD PhD, Harsh Patel, BS, Vaijayanthi Kandadai Raghavan, Aaron Goodman, Tamara G. Barnes, Razelle Kurzrock, MD

Blood (2019) 134 (Supplement_1): 2319.

https://doi.org/10.1182/blood-2019-126342

Published: 2019

Journal Articles

A Comparison between Two Risk Stratification Schemes for Allogeneic Transplant for Acute Myeloid Leukemia—Implications for Defining Expected Outcomes

Harsh Patel, BS, Alfonso Molina, BS, Mina Nikanjam, MD, Gary J. Schiller, MD

Blood (2017) 130 (Supplement 1): 5547.

https://doi.org/10.1182/blood.V130.Suppl_1.5547.5547

Published: 2017

Journal Articles

Risk Factors for Relapse Following Allogeneic Transplant for Acute Myeloid Leukemia in the UCLA Patient Population

Harsh Patel, Alfonso Molina, BS, Mina Nikanjam, MDPhD, Gary J. Schiller, MD

Blood (2016) 128 (22): 5855.

https://doi.org/10.1182/blood.V128.22.5855.5855

Published: 2016

Journal Articles

Cladribine for the Management of Erdheim-Chester Histiocytosis in Adults

Harsh Patel, Cary Kraft, Gary J. Schiller, MD FACP

Blood (2014) 124 (21): 5551.

https://doi.org/10.1182/blood.V124.21.5551.5551

Published: 2014

NARROW

Reduced-Intensity Versus Myeloablative Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials & Cohort Studies

MEK Inhibition with Trametinib in Patients with Non-Langerhans Cell Histiocytosis

A Comparison between Two Risk Stratification Schemes for Allogeneic Transplant for Acute Myeloid Leukemia—Implications for Defining Expected Outcomes

Risk Factors for Relapse Following Allogeneic Transplant for Acute Myeloid Leukemia in the UCLA Patient Population

Cladribine for the Management of Erdheim-Chester Histiocytosis in Adults

Email alerts

ASH Publications

American Society of Hematology

Reduced-Intensity Versus Myeloablative Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials & Cohort Studies

MEK Inhibition with Trametinib in Patients with Non-Langerhans Cell Histiocytosis

A Comparison between Two Risk Stratification Schemes for Allogeneic Transplant for Acute Myeloid Leukemia—Implications for Defining Expected Outcomes

Risk Factors for Relapse Following Allogeneic Transplant for Acute Myeloid Leukemia in the UCLA Patient Population

Cladribine for the Management of Erdheim-Chester Histiocytosis in Adults

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only